186 related articles for article (PubMed ID: 9820505)
1. The nephritogenic T cell response in murine chronic graft-versus-host disease.
Meyers CM; Tomaszewski JE; Glass JD; Chen CW
J Immunol; 1998 Nov; 161(10):5321-30. PubMed ID: 9820505
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease.
Williamson E; Garside P; Bradley JA; More IA; Mowat AM
J Immunol; 1997 Aug; 159(3):1208-15. PubMed ID: 9233615
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory effects of interferon-gamma on autoreactive nephritogenic T-cell clones.
Meyers CM; Zhang Y
Kidney Int; 1999 Apr; 55(4):1395-406. PubMed ID: 10201004
[TBL] [Abstract][Full Text] [Related]
4. Differential cytokine expression in acute and chronic murine graft-versus-host-disease.
Allen RD; Staley TA; Sidman CL
Eur J Immunol; 1993 Feb; 23(2):333-7. PubMed ID: 8436168
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic MHC antigen requirements for lupus-like autoantibody production and nephritis in murine graft-vs-host disease.
Portanova JP; Ebling FM; Hammond WS; Hahn BH; Kotzin BL
J Immunol; 1988 Nov; 141(10):3370-6. PubMed ID: 3263424
[TBL] [Abstract][Full Text] [Related]
6. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
[TBL] [Abstract][Full Text] [Related]
7. In vivo reactivity of T cell clones isolated from mice with syngeneic graft-versus-host disease.
Bryson JS; Lake-Bullock H; Pflugh DL; Jennings CD; Stuart PM; Caywood BE; Kaplan AM
Transplantation; 1995 Jul; 60(2):171-8. PubMed ID: 7624959
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M
Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
Chen W; Thoburn C; Hess AD
J Immunol; 1998 Dec; 161(12):7040-6. PubMed ID: 9862741
[TBL] [Abstract][Full Text] [Related]
10. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
11. Mixed haplotype A beta Z/A alpha d class II molecule in (NZB x NZW)F1 mice detected by T cell clones.
Gotoh Y; Takashima H; Noguchi K; Nishimura H; Tokushima M; Shirai T; Kimoto M
J Immunol; 1993 Jun; 150(11):4777-87. PubMed ID: 8496588
[TBL] [Abstract][Full Text] [Related]
12. Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors.
Ellison CA; Taniguchi M; Fischer JM; Hayglass KT; Gartner JG
Immunology; 2006 Nov; 119(3):338-47. PubMed ID: 16879624
[TBL] [Abstract][Full Text] [Related]
13. Natural killer activity in (C57BL/6 X DBA/2)F1 hybrids undergoing acute and chronic graft-vs.-host reaction.
Pattengale PK; Ramstedt U; Gidlund M; Orn A; Axberg I; Wigzell H
Eur J Immunol; 1983 Nov; 13(11):912-9. PubMed ID: 6641788
[TBL] [Abstract][Full Text] [Related]
14. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
Ellison CA; Fischer JM; HayGlass KT; Gartner JG
J Immunol; 1998 Jul; 161(2):631-40. PubMed ID: 9670937
[TBL] [Abstract][Full Text] [Related]
15. The isolation and functional characterization of autoimmune clones expressing inappropriate Ia.
Cronin PS; Sing AP; Glimcher LH; Kelley VE; Reinisch CL
J Immunol; 1984 Aug; 133(2):822-9. PubMed ID: 6610712
[TBL] [Abstract][Full Text] [Related]
16. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
[TBL] [Abstract][Full Text] [Related]
17. CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in acute graft-versus-host disease.
Streeter PR; Zhang X; Tittle TV; Schön CN; Weinberg AD; Maziarz RT
Biol Blood Marrow Transplant; 2004 May; 10(5):298-309. PubMed ID: 15111929
[TBL] [Abstract][Full Text] [Related]
18. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
19. IL-12 is a central mediator of acute graft-versus-host disease in mice.
Williamson E; Garside P; Bradley JA; Mowat AM
J Immunol; 1996 Jul; 157(2):689-99. PubMed ID: 8752918
[TBL] [Abstract][Full Text] [Related]
20. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.
Thoburn CJ; Miura Y; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Sep; 10(9):591-603. PubMed ID: 15319771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
